IGF1 and endothelial dysfunction: The LI-IGF-I−/− mice have compensated insulin resistance with unchanged blood glucose level [29], reduced cardiac output [32], increased systolic blood pressure associated with increased peripheral vascular resistance [32], and signs of endothelial dysfunction associated with impaired vasorelaxation of resistance vessels [32].